Richard R Rubin1, Mark Peyrot. 1. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. rrubin4@jhmi.edu
Abstract
BACKGROUND: Little is known about how the most advanced technology affects treatment satisfaction and health-related quality of life (HRQOL) in adults with diabetes. This study was designed to assess treatment satisfaction and HRQOL among users of an integrated real-time (RT) continuous glucose monitoring (CGM)/continuous subcutaneous insulin infusion (CSII) system compared with those using self-monitoring of blood glucose (SMBG) with CSII. METHODS: Participants were 311 adult respondents to an Internet survey, 162 using RT-CGM/CSII, 149 using SMBG + CSII (median age 43 years; type 1 diabetes 94%; diabetes duration >15 years 61%; median insulin use 15 years). Respondents completed instruments assessing glucose monitoring system and insulin delivery system convenience, interference, burden, glucose control efficacy, cost satisfaction, overall satisfaction, and treatment preference, as well as quality of life (diabetes-related worries, social burden, and psychological well-being). Real-time CGM/CSII users also assessed specific elements of the RT-CGM/CSII system. Group differences were assessed using analysis of covariance controlling for respondent characteristics. RESULTS: The RT-CGM/CSII group gave significantly better ratings than the SMBG + CSII group for their glucose monitoring system's glucose control efficacy, overall satisfaction, desire to switch, and willingness to recommend, and significantly worse ratings for interference with daily activities. The RT-CGM/CSII group gave significantly better ratings than the SMBG + CSII group for their insulin delivery system's convenience and glucose control efficacy, overall satisfaction, desire to switch, and willingness to recommend. Real-time CGM/CSII users gave positive ratings of all system features. CONCLUSIONS: Users of the integrated RT-CGM/CSII system reported more benefits of treatment, higher treatment satisfaction and quality of life, and greater preference for this system than SMBG + CSII users.
BACKGROUND: Little is known about how the most advanced technology affects treatment satisfaction and health-related quality of life (HRQOL) in adults with diabetes. This study was designed to assess treatment satisfaction and HRQOL among users of an integrated real-time (RT) continuous glucose monitoring (CGM)/continuous subcutaneous insulin infusion (CSII) system compared with those using self-monitoring of blood glucose (SMBG) with CSII. METHODS:Participants were 311 adult respondents to an Internet survey, 162 using RT-CGM/CSII, 149 using SMBG + CSII (median age 43 years; type 1 diabetes 94%; diabetes duration >15 years 61%; median insulin use 15 years). Respondents completed instruments assessing glucose monitoring system and insulin delivery system convenience, interference, burden, glucose control efficacy, cost satisfaction, overall satisfaction, and treatment preference, as well as quality of life (diabetes-related worries, social burden, and psychological well-being). Real-time CGM/CSII users also assessed specific elements of the RT-CGM/CSII system. Group differences were assessed using analysis of covariance controlling for respondent characteristics. RESULTS: The RT-CGM/CSII group gave significantly better ratings than the SMBG + CSII group for their glucose monitoring system's glucose control efficacy, overall satisfaction, desire to switch, and willingness to recommend, and significantly worse ratings for interference with daily activities. The RT-CGM/CSII group gave significantly better ratings than the SMBG + CSII group for their insulin delivery system's convenience and glucose control efficacy, overall satisfaction, desire to switch, and willingness to recommend. Real-time CGM/CSII users gave positive ratings of all system features. CONCLUSIONS: Users of the integrated RT-CGM/CSII system reported more benefits of treatment, higher treatment satisfaction and quality of life, and greater preference for this system than SMBG + CSII users.
Authors: E Berthe; B Lireux; C Coffin; B Goulet-Salmon; D Houlbert; S Boutreux; S Fradin; Y Reznik Journal: Horm Metab Res Date: 2007-03 Impact factor: 2.936
Authors: D Bruttomesso; A Pianta; D Crazzolara; E Scaldaferri; L Lora; G Guarneri; A Mongillo; R Gennaro; M Miola; M Moretti; L Confortin; G P Beltramello; M Pais; A Baritussio; E Casiglia; A Tiengo Journal: Diabet Med Date: 2002-08 Impact factor: 4.359
Authors: Stuart Weinzimer; Dongyuan Xing; Michael Tansey; Rosanna Fiallo-Scharer; Nelly Mauras; Tim Wysocki; Roy Beck; William Tamborlane; Katrina Ruedy Journal: Diabetes Care Date: 2007-12-20 Impact factor: 19.112
Authors: Irl B Hirsch; Jill Abelseth; Bruce W Bode; Jerome S Fischer; Francine R Kaufman; John Mastrototaro; Christopher G Parkin; Howard A Wolpert; Bruce A Buckingham Journal: Diabetes Technol Ther Date: 2008-10 Impact factor: 6.118
Authors: William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing Journal: N Engl J Med Date: 2008-09-08 Impact factor: 91.245
Authors: Laurel H Messer; Paul F Cook; Molly L Tanenbaum; Sarah Hanes; Kimberly A Driscoll; Korey K Hood Journal: J Diabetes Sci Technol Date: 2019-03-10
Authors: Molly L Tanenbaum; Rebecca N Adams; Sarah J Hanes; Regan C Barley; Kellee M Miller; Shelagh A Mulvaney; Korey K Hood Journal: J Diabetes Sci Technol Date: 2017-01-10
Authors: Gregory P Forlenza; Laurel H Messer; Cari Berget; R Paul Wadwa; Kimberly A Driscoll Journal: Curr Diab Rep Date: 2018-09-26 Impact factor: 4.810
Authors: David T Eton; Tarig A Elraiyah; Kathleen J Yost; Jennifer L Ridgeway; Anna Johnson; Jason S Egginton; Rebecca J Mullan; Mohammad Hassan Murad; Patricia J Erwin; Victor M Montori Journal: Patient Relat Outcome Meas Date: 2013-06-05